Cancer stem cells and lymph node metastasis in early stage breast cancer (2010)
- Authors:
- USP affiliated authors: CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; SILVA, JOÃO SANTANA DA - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; TIÉZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS MAMÁRIAS; CÉLULAS-TRONCO; METÁSTASE LINFÁTICA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2010
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the American Association for Cancer Research (AACR)
-
ABNT
TIEZZI, Daniel Guimarães et al. Cancer stem cells and lymph node metastasis in early stage breast cancer. 2010, Anais.. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 15 fev. 2026. -
APA
Tiezzi, D. G., Valejo, F. A. M., Marana, H. R. C., Clagnan, W. S., Benides, L., Carrara, H. H. A., et al. (2010). Cancer stem cells and lymph node metastasis in early stage breast cancer. In Abstracts. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Tiezzi DG, Valejo FAM, Marana HRC, Clagnan WS, Benides L, Carrara HHA, Silva JS, Andrade JM. Cancer stem cells and lymph node metastasis in early stage breast cancer. Abstracts. 2010 ;[citado 2026 fev. 15 ] -
Vancouver
Tiezzi DG, Valejo FAM, Marana HRC, Clagnan WS, Benides L, Carrara HHA, Silva JS, Andrade JM. Cancer stem cells and lymph node metastasis in early stage breast cancer. Abstracts. 2010 ;[citado 2026 fev. 15 ] - Quality of life in women with breast cancer treated with or without chemotherapy
- IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment
- HIF-1'alfa' and locally advanced breast cancer [Carta]
- CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast
- Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
- Idade como fator independente de prognóstico no câncer de mama
- Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
